What is the official website of MANKIND PHARMA LTD ?

The official website of MANKIND PHARMA LTD is http://www.mankindpharma.com.

What is MANKIND PHARMA LTD's cybersecurity risk score?

MANKIND PHARMA LTD has an AI-generated cybersecurity risk score of 781 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has MANKIND PHARMA LTD experienced?

According to Rankiteo, MANKIND PHARMA LTD currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has MANKIND PHARMA LTD been affected by any supply chain cyber incidents ?

According to Rankiteo, MANKIND PHARMA LTD has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does MANKIND PHARMA LTD have SOC 2 Type 1 certification ?

According to Rankiteo, MANKIND PHARMA LTD is not certified under SOC 2 Type 1.

Does MANKIND PHARMA LTD have SOC 2 Type 2 certification ?

According to Rankiteo, MANKIND PHARMA LTD does not hold a SOC 2 Type 2 certification.

Does MANKIND PHARMA LTD comply with GDPR ?

According to Rankiteo, MANKIND PHARMA LTD is not listed as GDPR compliant.

Does MANKIND PHARMA LTD have PCI DSS certification ?

According to Rankiteo, MANKIND PHARMA LTD does not currently maintain PCI DSS compliance.

Does MANKIND PHARMA LTD comply with HIPAA ?

According to Rankiteo, MANKIND PHARMA LTD is not compliant with HIPAA regulations.

Does MANKIND PHARMA LTD have ISO 27001 certification ?

According to Rankiteo,MANKIND PHARMA LTD is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does MANKIND PHARMA LTD operate in ?

MANKIND PHARMA LTD operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does MANKIND PHARMA LTD have ?

MANKIND PHARMA LTD employs approximately 19,230 people worldwide.

Does MANKIND PHARMA LTD own any subsidiaries ?

MANKIND PHARMA LTD presently has no subsidiaries across any sectors.

How many LinkedIn followers does MANKIND PHARMA LTD have ?

MANKIND PHARMA LTD's official LinkedIn profile has approximately 15,485 followers.

What is the NAICS classification code for MANKIND PHARMA LTD ?

MANKIND PHARMA LTD is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does MANKIND PHARMA LTD have a Crunchbase profile ?

No, MANKIND PHARMA LTD does not have a profile on Crunchbase.

Does MANKIND PHARMA LTD have a LinkedIn profile ?

Yes, MANKIND PHARMA LTD maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/mankind-pharma-ltd.

How many cybersecurity incidents has MANKIND PHARMA LTD experienced ?

As of September 12, 2026, Rankiteo reports that MANKIND PHARMA LTD has not experienced any cybersecurity incidents.

How many peer or competitor companies does MANKIND PHARMA LTD have ?

MANKIND PHARMA LTD has an estimated 5,760 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MPL

Boost Score +25 with badge (5 left)

781

/1000

Fair

806

/1000

Good

MANKIND PHARMA LTD Vendor Cyber Rating & Cyber Score

mankindpharma.com

Add Your Compliance Badge

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS

MPL

MANKIND PHARMA LTD CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

MPL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MPL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MANKIND PHARMA LTD in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for MANKIND PHARMA LTD in 2026.

Incident Types MPL vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MANKIND PHARMA LTD in 2026.

Incident History - MPL (X = Date, Y = Severity)

Loading…

SUBSIDIARY

MANKIND PHARMA LTD Subsidiaries

Parent Company

MPL

Pharmaceutical Manufacturing

Website: http://www.mankindpharma.com

Company Size: 10,001+ employees

No subsidiary data available for this company.

Loading…

MANKIND PHARMA LTD Similar Companies

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Hikma Pharmaceuticals

cb hikma.com

For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists need to treat their patients across North America, MENA and Europe. We have 29 manufacturing plants, 3 R&D hubs and c9,500 employees worldwide. *As of December 2025 Subscribe to our channel on YouTube https://youtube.com/@hikmapharmaceuticals5668 For all product information and enquiries, please contact us at [email protected]

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Johnson & Johnson Innovative Medicine

cb jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Loading…

NEWS

MANKIND PHARMA LTD CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 16, 2026 12:57 PM

Mankind Pharma Reinvents Global Supply Chain and Procurement with Accenture

Mankind Pharma, India's fourth-largest pharmaceutical company, has completed a large-scale, multi-year transformation of its global supply...

Read Article

September 18, 2025 07:00 AM

Apollo Micro Systems Forges Cybersecurity Alliances with Sibersentinel and Zoom Technologies

Apollo Micro Systems Limited (AMSL) has signed MoUs with Sibersentinel Technologies Limited and Zoom Technologies (India) Private Limited to...

Read Article

July 30, 2025 07:00 AM

Akums Appoints Tarun Kapoor as CIO to Accelerate Its Digital Transformation Journey

Akums Drugs & Pharmaceuticals Ltd. has appointed Tarun Kapoor as its new Chief Information Officer (CIO).

Read Article

July 29, 2025 07:00 AM

Tarun Kapoor to lead tech and digital affairs at Akums Drugs & Pharmaceuticals

Akums Drugs & Pharmaceuticals, a contract development and manufacturing company in the pharma sector, has appointed Tarun Kapoor as Senior...

Read Article

July 26, 2025 07:00 AM

IRDAI Slaps ₹3.39 Crore Penalty on Star Health for Cyber Security Violations

Star Health and Allied Insurance Company has been penalized ₹3.39 crore by IRDAI for violating Information & Cyber Security Guidelines,...

Read Article

September 16, 2024 09:20 AM

About Summit

150+ of these tech decision makers from leading enterprises in Bangalore and the technology solution providers at the APAC CXO Summit & Awards on 29th November...

Read Article

September 04, 2024 07:00 AM

Celebrating Pharma Excellence & Innovation: The 6th Elets Pharma Leadership Summit & Awards 2024

The event garnered deep insights into current trends, challenges, and opportunities, engaging over 175 senior delegates, industry leaders, and innovators.

Read Article

July 10, 2024 07:00 AM

'Happened in 2023': Angel One responds to report of data leak of 8 mn users

Angel One data leak: The hacker claims to have accessed sensitive data, including profit and loss statements of affected customers of the...

Read Article

February 28, 2024 07:32 AM

APAC CXO Summit & Awards 2024, New Delhi

APAC News Network is organizing a 1-day gathering of 50+ IT and security decision makers from these large enterprises in Hotel Lalit, New Delhi on 19th April,...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-90461

SUMMARY

OpenStack Ironic through 38.0.0 may send a username and password to an unexpected remote host when Image Service is configured for HTTP(S) Basic Authentication.

Published

Date2026-09-11

Updated

Date2026-09-11

RISK INFORMATION (Score: 6.3)

cvss3

Base Score: 6.3

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:N/A:N

Impact Score

Exploitability

1.8

REFERENCES

https://bugs.launchpad.net/ironic/+bug/2162816

CVE-2026-90460

SUMMARY

An issue was discovered in OpenStack Keystone before 29.0.3. Tokens obtained via delegated authentication methods (EC2 credentials, application credentials, OAuth1 access tokens, and trusts) are not blocked from creating, modifying, or deleting credentials via the /v3/credentials API. EC2-derived tokens can additionally read credential blobs, exposing TOTP MFA seeds and other secrets. Also, PATCH /v3/credentials does not validate the requested post-update project_id, allowing any delegated token to move a credential to an unauthorized project. All Keystone deployments using delegated authentication are affected.

Published

Date2026-09-11

Updated

Date2026-09-11

RISK INFORMATION (Score: )

cvss4

Base Score: 7.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-90457

SUMMARY

The administrative password is hashed using a comparatively weak, fast algorithm for the credential store backing one authentication path, and the file containing that hash is written with permissions allowing it to be read by any local user. This is inconsistent with a separate, stronger hashing algorithm used for the same password on another authentication path. A party able to read this file, including a local user or a party with access to a configuration backup, could feasibly recover the underlying password through offline computation, compromising the administrative credential across every path that accepts it.

Published

Date2026-09-11

Updated

Date2026-09-11

RISK INFORMATION (Score: )

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2026/icsa-26-254-01.json

CVE-2026-90456

SUMMARY

An example environment-configuration file for a bundled inventory-management component ships with a fixed, publicly-known administrative password. A deployment that copies this example file into active configuration without running the setup routine that regenerates credentials will expose that component's administrative interface to anyone aware of the default value.

Published

Date2026-09-11

Updated

Date2026-09-11

RISK INFORMATION (Score: )

cvss4

Base Score: 9.2

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2026/icsa-26-254-01.json

CVE-2026-90455

SUMMARY

A prior update that raised a bundled HTTP client library to a version remediating known vulnerabilities was later reverted, reintroducing the earlier, vulnerable version into a log-processing component. The only code path in that component using the library issues a request to a single fixed, trusted vendor URL at initialization and does not process attacker-controlled input through the library, limiting practical exploitability of the reintroduced version in this context.

Published

Date2026-09-11

Updated

Date2026-09-11

RISK INFORMATION (Score: )

cvss4

Base Score: 6.3

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

https://raw.githubusercontent.com/cisagov/CSAF/develop/csaf_files/OT/white/2026/icsa-26-254-01.json

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

MANKIND PHARMA LTD Vendor Cyber Rating & Cyber Score

MPL A.I CyberSecurity Scoring

MANKIND PHARMA LTD CyberSecurity News & History

MPL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MPL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MPL vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MPL (X = Date, Y = Severity)

MANKIND PHARMA LTD Subsidiaries

Parent Company

MPL

MANKIND PHARMA LTD Similar Companies

Sanofi

Eli Lilly and Company

MSD

Hikma Pharmaceuticals

Catalent

Novo Nordisk

Johnson & Johnson Innovative Medicine

Zoetis

Merck Group

MANKIND PHARMA LTD CyberSecurity News

Mankind Pharma Reinvents Global Supply Chain and Procurement with Accenture

Apollo Micro Systems Forges Cybersecurity Alliances with Sibersentinel and Zoom Technologies

Akums Appoints Tarun Kapoor as CIO to Accelerate Its Digital Transformation Journey

Tarun Kapoor to lead tech and digital affairs at Akums Drugs & Pharmaceuticals

IRDAI Slaps ₹3.39 Crore Penalty on Star Health for Cyber Security Violations

About Summit

Celebrating Pharma Excellence & Innovation: The 6th Elets Pharma Leadership Summit & Awards 2024

'Happened in 2023': Angel One responds to report of data leak of 8 mn users

APAC CXO Summit & Awards 2024, New Delhi

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

MANKIND PHARMA LTD CyberSecurity News & History

MPL Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MPL

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MPL vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MPL (X = Date, Y = Severity)

MANKIND PHARMA LTD Subsidiaries

Parent Company

MPL

MANKIND PHARMA LTD Similar Companies

Sanofi

Eli Lilly and Company

MSD

Hikma Pharmaceuticals

Catalent

Novo Nordisk

Johnson & Johnson Innovative Medicine

Zoetis

Merck Group

MANKIND PHARMA LTD CyberSecurity News

Mankind Pharma Reinvents Global Supply Chain and Procurement with Accenture

Apollo Micro Systems Forges Cybersecurity Alliances with Sibersentinel and Zoom Technologies

Akums Appoints Tarun Kapoor as CIO to Accelerate Its Digital Transformation Journey

Tarun Kapoor to lead tech and digital affairs at Akums Drugs & Pharmaceuticals

IRDAI Slaps ₹3.39 Crore Penalty on Star Health for Cyber Security Violations

About Summit

Celebrating Pharma Excellence & Innovation: The 6th Elets Pharma Leadership Summit & Awards 2024

'Happened in 2023': Angel One responds to report of data leak of 8 mn users

APAC CXO Summit & Awards 2024, New Delhi

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?